Non-small cell lung cancers

Clinical trials for Non-small cell lung cancers explained in plain language.

Never miss a new study

Get alerted when new Non-small cell lung cancers trials appear

Sign up with your email to follow new studies for Non-small cell lung cancers, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1 Terminated 2

New drug targets Hard-to-Treat cancers with rare gene mutation

Disease control Completed

This early-stage study tested a new drug called PRT3789, alone or with chemotherapy (docetaxel), in people with advanced solid tumors that have a specific change in the SMARCA4 gene. The main goals were to check safety, find the best dose, and see if the drug shrinks tumors. 135 …

Matched conditions: NON-SMALL CELL LUNG CANCERS

Phase 1 • Sponsor: Prelude Therapeutics • Aim: Disease control

Last updated Jun 27, 2026 07:54 UTC

Non-small cell lung cancers

Get alerted when new Non-small cell lung cancers trials appear

New drug targets Hard-to-Treat cancers with rare gene mutation